MAPT and Alzheimer disease: Importantly, multiple studies have shown that miR-132 is the most downregulated miRNA in postmortem AD brain with reductions in miR-132 occurring before neuronal loss and associated with progression of both amyloid and Tau pathology [22, 31, 45, 46, 53, 67].